SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix's upcoming earnings are sparking active debate, especially after the stock traded down in the after-hours session. While revenue was in line with estimates, EPS missed, and some community members are attributing the dip to a tax dispute in Brazil and broader concerns about content. A potential stock split and the impact of increased competition and advertising revenue are also key talking points.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending due to its acquisition of Railbird, a prediction market platform, sparking discussions about the company's expansion into new markets beyond sports betting. While some express excitement about this growth and potential, others are skeptical, citing concerns about profitability and regulatory challenges, with community members closely watching how this move impacts the stock's value.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to a proposed private offering of convertible senior notes, leading to community discussion about dilution and its impact on long-term holders; some view this as a strategic move to secure funding before positive catalysts, while others express concern about the company's financial management and potential for further offerings; the community is also debating the recent analyst downgrade and its effect on the stock's trajectory.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending due to anticipation surrounding its upcoming earnings report, with the community actively discussing potential outcomes and guidance. Bullish sentiment suggests the company will beat expectations, driven by strong global adoption of its da Vinci systems and procedure growth, despite concerns about tariffs and margin pressures. Traders are also closely monitoring unusual options activity and technical indicators for potential short-term opportunities.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is trending following its latest earnings report, with revenue exceeding expectations but EPS falling slightly short, leading to mixed sentiment. The community is actively discussing whether the results justify the stock's valuation amidst broader concerns about the macro environment and potential tariff impacts. Some believe TXN is undervalued and poised for a rally, while others are wary of the company's guidance and competitive landscape.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending as the stock experiences a significant pullback, prompting community discussion about potential bottom levels and future catalysts. Despite the recent downturn, some investors express confidence in the company's long-term prospects, citing a major deal with Microsoft and overall growth in the AI sector. Community members are actively debating whether to buy the dip or wait for further price declines.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amidst speculation of a potential acquisition, with Paramount Skydance reportedly interested in making a bid, although the deal's likelihood is debated. Community chatter revolves around potential offer prices and whether WBD will accept, with some anticipating a bidding war involving other major players like Netflix or Comcast. The stock's movement reflects investor uncertainty surrounding these ongoing acquisition rumors and what price a deal could actually happen at.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

Minerva Neurosciences ($NERV) is trending due to a massive surge following news of a $200M financing deal aimed at advancing its schizophrenia treatment. Community chatter revolves around the potential for significant gains, while some traders caution about a possible pump and dump, leading to high volatility. The funding is viewed as a strong indicator of confidence in the drug's approval, sparking debates about its long-term potential versus short-term trading opportunities.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs experienced a volatile trading period, initially surging on rare earth mining prospects and fixed-price automotive contracts. However, the stock quickly reversed course following an analyst downgrade and skepticism regarding the viability of the rare earth initiative. Community discussions center on potential acquisitions, the impact of analyst ratings, and overall market manipulation.

Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman, and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.

Sweetgreen Inc - Ordinary Shares - Class A

Sweetgreen ($SG) is trending as chatter suggests a potential short squeeze ahead of earnings, with community members noting high put/call ratios and significant options activity. Some investors believe the stock is oversold and undervalued, especially given its robotics technology from the SPYCE acquisition, while others are eyeing it as a sympathy play with other heavily shorted stocks like BYND making moves. Community members are actively discussing the potential for a gamma squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval

STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.

ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?

Intuitive Surgical shares are down 13% in three months as margin pressures weigh on the stock, but strong procedure growth keeps its long-term story intact.

SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?

Intuitive Surgical's SP platform posts 88% procedure growth in Q2, driven by a 112% surge in Korea and expanding adoption in colorectal and thoracic surgery.

PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates

PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +14.63% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates

AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of +26.32% and +0.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates

Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of -10.34% and +39.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know

PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Short seller Spruce Point targets Procept on overestimation of market size

Investing.com -- Short seller Spruce Point Capital Management expressed concern over  Procept Biorobotics  Corp (NASDAQ:PRCT)’s growth prospects, market size estimates, and safety of its robotic surgical procedures.

&nbsp;1) Butterfly Network (NYSE: BFLY)<ul><li>Background: Butterfly Network is a digital health company pioneering accessible ultrasound technology through its handheld devices, with a mission to democratize high-quality imaging. The Butterfly iQ series has applications in multiple healthcare settings, enabling diagnostic imaging that is portable, affordable, and accessible.</li><li>The News: Butterfly Network recently partnered with HeartFocus to launch an AI-driven training app for cardiac ultrasound, compatible with Butterfly’s portable iQ devices. The app is designed to help healthcare practitioners acquire essential diagnostic skills, even in remote and underserved areas, boosting Butterfly’s appeal to health professionals globally.</li><li>What It Means: This partnership aligns with Butterfly’s vision of expanding ultrasound accessibility, particularly in resource-limited settings. By combining advanced AI-powered education with Butterfly’s handheld devices, the company positions itself as a leader in mobile diagnostics. As demand for accessible healthcare tech grows, Butterfly Network’s innovation could drive significant adoption and revenue growth.</li><li>Stock Reaction: Shares of BFLY rose 3.8%, with trading volume showing heightened interest following the announcement. Investors appear optimistic that AI integrations will boost device uptake, especially among hospitals and clinics focused on remote care.</li><li>Stocktwits Insight:&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_29_at_3_20_24_AM_903272e4bf.png" alt="Screenshot 2024-10-29 at 3.20.24 AM.png"></li></ul>&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/tech/all-systems-go-ast-spacemobile-asts-stock-throttles-up-en-route-to-the-stars/">Read now: This Space Stock is up 1,700% From $2 on a Mega Telecom Deal– is This the First of Many Contracts? or is it Headed Back to Penny Land? We Have the Inside Scoop</a>&nbsp;2) Gilat Satellite Networks (NASDAQ: GILT)<ul><li>Background: With over 35 years of experience, Gilat Satellite Networks specializes in satellite-based broadband communication solutions, catering to sectors like government, defense, and enterprise. Known for its high-quality and scalable communication systems, Gilat has a strong global reputation in satellite technology.</li><li>The News: Gilat was awarded a $4 million contract from the U.S. Department of Defense to supply DKET 3421 terminals, versatile communication hubs designed for field deployment. These terminals will enhance mission-critical communications, providing secure, mobile connectivity in challenging environments.</li><li>What It Means: This contract reinforces Gilat’s standing as a trusted defense partner, underscoring the value of its portable satellite solutions in national security contexts. Such government contracts bring stable revenue and validate Gilat’s reliability in high-stakes applications.</li><li>Stock Reaction: GILT shares rose 2.9% on above-average volume, reflecting investor confidence in Gilat’s steady pipeline of government contracts.</li><li>Stocktwits Insight: <img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_29_at_3_21_07_AM_975e4948a4.png" alt="Screenshot 2024-10-29 at 3.21.07 AM.png"></li></ul>&nbsp;3) Power Nickel (TSXV: PNPN)<ul><li>Background: Power Nickel, a Canadian junior exploration company, focuses on nickel and other essential metals used in electric vehicle (EV) batteries. Its primary asset, the Nisk property in Quebec, has yielded high-grade nickel and copper, attracting attention within the green tech sector.</li><li>The News: Power Nickel announced promising drill results from the Lion Zone, with intersections showing high concentrations of copper, gold, and palladium. These results enhance the project’s profile, potentially making Power Nickel a key player in sustainable, North American-based battery metals.</li><li>What It Means: With demand for nickel and battery metals on the rise, Power Nickel’s findings position it well to meet the needs of EV manufacturers seeking local, reliable sources. The results are likely to attract both investment and strategic partnerships within the green energy sector.</li><li>Stock Reaction: PNPN shares fell 2.41%, with trading volume up almost 100% from average indicating growing investor enthusiasm for Power Nickel’s expansion potential.</li><li>Stocktwits Insight: <img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_29_at_3_21_17_AM_62f6fd842f.png" alt="Screenshot 2024-10-29 at 3.21.17 AM.png"></li></ul>&nbsp;4) Genprex (NASDAQ: GNPX)<ul><li>Background: Genprex is a gene therapy company focused on cancer and diabetes treatments. Its flagship product, Reqorsa, aims to restore tumor-suppressor gene function in cancer patients, showing promise in treating resistant forms of lung cancer.</li><li>The News: Genprex presented positive preclinical data on Reqorsa, showcasing potential effectiveness against KRAS-resistant lung cancer, glioblastoma, and mesothelioma. This data, shared at an international symposium, underscores Reqorsa’s potential as a versatile cancer therapy.</li><li>What It Means: These findings reinforce Genprex’s pipeline credibility and could lay the groundwork for future clinical trials. If further studies replicate these results, Genprex may secure institutional investment as the therapy advances toward regulatory milestones.</li><li>Stock Reaction: GNPX shares surged 38.4% on higher-than-normal volume, as the announcement generated interest among investors.</li><li>Stocktwits Insight:&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_29_at_3_21_26_AM_dab873c609.png" alt="Screenshot 2024-10-29 at 3.21.26 AM.png"></li></ul>&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/tech/all-systems-go-ast-spacemobile-asts-stock-throttles-up-en-route-to-the-stars/">Read now: This Space Stock is up 1,700% From $2 on a Mega Telecom Deal– is This the First of Many Contracts? or is it Headed Back to Penny Land? We Have the Inside Scoop</a>&nbsp;5) Monte Rosa Therapeutics (NASDAQ: GLUE)<ul><li>Background: Monte Rosa Therapeutics is developing molecular glue degraders, which eliminate disease-causing proteins. This unique drug class has potential applications in autoimmune diseases, inflammation, and other conditions with few existing treatments.</li><li>The News: Monte Rosa announced a $150 million licensing agreement with Novartis to accelerate its VAV1-directed drug development program. The agreement provides Monte Rosa with significant financial backing to pursue its pipeline.</li><li>What It Means: Partnering with Novartis offers Monte Rosa access to substantial resources and validation for its innovative therapy approach. This collaboration could enhance Monte Rosa’s position within the biotech landscape, while boosting investor confidence.</li><li>Stock Reaction: GLUE shares jumped 93.9% as trading volume spiked, 27,000% reflecting market approval of the deal’s long-term growth potential.</li><li>Stocktwits Insight:&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_29_at_3_21_35_AM_fced9c05f9.png" alt="Screenshot 2024-10-29 at 3.21.35 AM.png"></li></ul>&nbsp;6) Atlas Lithium (NASDAQ: ATLX)<ul><li>Background: Atlas Lithium is a lithium exploration and development company working on the Neves project in Brazil’s “Lithium Valley.” With the global shift toward EVs and renewable energy storage, lithium is in high demand for battery production.</li><li>The News: Atlas secured regulatory permits to proceed with lithium extraction and processing at the Neves site. These approvals allow Atlas to develop a processing plant, positioning it to become a lithium supplier in the rapidly expanding EV battery market.</li><li>What It Means: This milestone accelerates Atlas’s journey to become a key player in the lithium supply chain. As EV adoption grows, Atlas’s Neves project may play a crucial role in meeting global lithium demand.</li><li>Stock Reaction: ATLX shares gained 24.7% on increased trading volume (5x), as investors anticipate the project’s potential impact on Atlas’s valuation.</li><li>Stocktwits Insight:&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_29_at_3_21_43_AM_6743660382.png" alt="Screenshot 2024-10-29 at 3.21.43 AM.png"></li></ul>&nbsp;7)Procept BioRobotics (NASDAQ: PRCT)<ul><li>Background: Procept BioRobotics specializes in robotic systems for urological procedures. Its AquaBeam Robotic System, a minimally invasive treatment for benign prostatic hyperplasia (BPH), has shown significant market growth.</li><li>The News: Procept reported strong Q3 earnings, driven by increased AquaBeam sales and consumables. The company raised its revenue guidance, signaling robust demand and operational growth.</li><li>What It Means: Procept’s earnings beat highlights its competitive edge in surgical robotics, particularly in the high-demand market for BPH treatment. The raised guidance reflects Procept’s confidence in continued market penetration and long-term revenue potential.</li><li>Stock Reaction: PRCT shares rose 32.3% on significant volume (6x), with investors responding positively to the improved financial outlook.</li><li>Stocktwits Insight:&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_29_at_3_22_05_AM_0dfbb455f8.png" alt="Screenshot 2024-10-29 at 3.22.05 AM.png"></li></ul>&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/tech/all-systems-go-ast-spacemobile-asts-stock-throttles-up-en-route-to-the-stars/">Read now: This Space Stock is up 1,700% From $2 on a Mega Telecom Deal– is This the First of Many Contracts? or is it Headed Back to Penny Land? We Have the Inside Scoop</a>&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/groups/WealthyVC">Join the Discussion on the WVC Facebook Investor Group</a><a target="_blank" rel="noopener noreferrer nofollow" href="http://www.stocktwits.com/wealthyvc">Follow us on Stocktwits</a>&nbsp;&nbsp;Have a Stock Tip or New Story Suggestion? Email us at: Invest@WealthyVC.comDisclaimer: Wealthy VC does not hold a long or short position in any of the stocks, ETFs or cryptocurrencies mentioned in this article.&nbsp;&nbsp;This article was written by an independent contributor and does not reflect the views of Stocktwits. It has not been edited for content. The information provided here is intended solely for informational and educational purposes, and should not be interpreted as investment advice. Stocktwits does not endorse the purchase or sale of any security nor does it make any claims about the financial status of any company.

Small and Micro-Cap Movers: Key News, Market Reactions, and Insider Chatter

Equity

Today’s most impactful small-cap stock updates, with exclusive rumors, insights, and analysis from StockTwits

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Procept BioRobotics Corp

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$34.61
Prev Close	$34.72
Open	$34.70
Dividend Yield	0.00%
50-Day Moving Average	$37.61
Beta	1.02
Avg. Volume	1.01M
PE Ratio	-22.30

52-Week High	$103.81
52-Week Low	$32.11
Market Capitalization	$1.93B
EPS (Annual)	-$1.75
Price to Book	5.00
Revenue Per Employee	$296,955.03
Enterprise Value/EBITDA	N/A

PRCT
Procept BioRobotics Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PRCT News

PRCTProcept BioRobotics Corp